Evogene Ltd. (EVGN.TA)
ILA 399.6
(2.72%)
ILA 399.6
(2.72%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 30.45 Million USD | 9.92% |
| 2022 | 27.7 Million USD | -10.96% |
| 2021 | 31.11 Million USD | 23.09% |
| 2020 | 25.28 Million USD | 17.12% |
| 2019 | 21.58 Million USD | 6.41% |
| 2018 | 20.28 Million USD | -9.78% |
| 2017 | 22.48 Million USD | 2.24% |
| 2016 | 21.99 Million USD | 5.75% |
| 2015 | 20.79 Million USD | 3.67% |
| 2014 | 20.05 Million USD | 23.91% |
| 2013 | 16.18 Million USD | 52.06% |
| 2012 | 10.64 Million USD | 8.22% |
| 2011 | 9.83 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.96 Million USD | 2.02% |
| 2024 Q2 | 6.47 Million USD | -18.67% |
| 2023 Q4 | 7.8 Million USD | 4.96% |
| 2023 FY | 30.45 Million USD | 9.92% |
| 2023 Q1 | 7.11 Million USD | 74.47% |
| 2023 Q2 | 8.09 Million USD | 13.76% |
| 2023 Q3 | 7.43 Million USD | -8.09% |
| 2022 FY | 27.7 Million USD | -10.96% |
| 2022 Q4 | 4.07 Million USD | -45.21% |
| 2022 Q3 | 7.44 Million USD | -7.62% |
| 2022 Q2 | 8.05 Million USD | -0.89% |
| 2022 Q1 | 8.12 Million USD | -6.95% |
| 2021 Q3 | 8.6 Million USD | 15.47% |
| 2021 FY | 31.11 Million USD | 23.09% |
| 2021 Q1 | 6.32 Million USD | -11.99% |
| 2021 Q2 | 7.45 Million USD | 17.91% |
| 2021 Q4 | 8.73 Million USD | 1.51% |
| 2020 Q2 | 5.41 Million USD | -21.53% |
| 2020 Q3 | 5.79 Million USD | 7.1% |
| 2020 FY | 25.28 Million USD | 17.12% |
| 2020 Q1 | 6.89 Million USD | -0.32% |
| 2020 Q4 | 7.18 Million USD | 23.96% |
| 2019 Q2 | 4.79 Million USD | -3.07% |
| 2019 Q4 | 6.91 Million USD | 40.31% |
| 2019 Q1 | 4.94 Million USD | -6.24% |
| 2019 FY | 21.58 Million USD | 6.41% |
| 2019 Q3 | 4.92 Million USD | 2.82% |
| 2018 FY | 20.28 Million USD | -9.78% |
| 2018 Q4 | 5.27 Million USD | 1.56% |
| 2018 Q3 | 5.19 Million USD | 8.5% |
| 2018 Q2 | 4.78 Million USD | -4.79% |
| 2018 Q1 | 5.02 Million USD | -17.83% |
| 2017 Q2 | 5.32 Million USD | -0.11% |
| 2017 Q3 | 5.7 Million USD | 7.08% |
| 2017 FY | 22.48 Million USD | 2.24% |
| 2017 Q4 | 6.11 Million USD | 7.28% |
| 2017 Q1 | 5.33 Million USD | -14.0% |
| 2016 Q1 | 5.08 Million USD | -12.72% |
| 2016 Q3 | 5.29 Million USD | -2.29% |
| 2016 FY | 21.99 Million USD | 5.75% |
| 2016 Q4 | 6.2 Million USD | 17.22% |
| 2016 Q2 | 5.41 Million USD | 6.47% |
| 2015 FY | 20.79 Million USD | 3.67% |
| 2015 Q4 | 5.82 Million USD | 26.54% |
| 2015 Q1 | 4.99 Million USD | -14.59% |
| 2015 Q2 | 5.36 Million USD | 7.34% |
| 2015 Q3 | 4.6 Million USD | -14.2% |
| 2014 Q1 | 3.91 Million USD | -30.19% |
| 2014 FY | 20.05 Million USD | 23.91% |
| 2014 Q4 | 5.85 Million USD | 14.03% |
| 2014 Q3 | 5.13 Million USD | -0.39% |
| 2014 Q2 | 5.15 Million USD | 31.49% |
| 2013 Q4 | 5.61 Million USD | 34.34% |
| 2013 Q1 | 2.96 Million USD | -3.92% |
| 2013 FY | 16.18 Million USD | 52.06% |
| 2013 Q2 | 3.42 Million USD | 15.46% |
| 2013 Q3 | 4.17 Million USD | 21.94% |
| 2012 Q2 | 2.67 Million USD | 0.0% |
| 2012 Q3 | 2.63 Million USD | -1.61% |
| 2012 Q4 | 3.08 Million USD | 17.19% |
| 2012 FY | 10.64 Million USD | 8.22% |
| 2011 FY | 9.83 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Matricelf Ltd | 11.78 Million ILA | -158.43% |